Nexera销毁3250万个代币-最新加密货币新闻

币界网Pubblicato 2024-08-08Pubblicato ultima volta 2024-08-08

币界网报道:

去中心化金融(DeFi)协议Nexera最近在一次黑客事件后焚烧了3250万个NXRA代币,这是他们加强安全战略的一部分。区块链安全公司PeckShieldAlert证实,这些代币已永久停止流通。

内容隐藏1 Nexera如何回应?2袭击期间发生了什么?3具体措施和建议

Nexera是如何回应的?

Nexera的官方X账户披露了为应对黑客攻击而采取的多项措施。他们的技术调查证实,智能合约是不妥协的。尽管如此,仍有价值约44万美元的NXRA代币被确定为已泄露。因此,Nexera冻结了黑客钱包中的3250万个NXRA代币,以防止进一步的损害。访问COINTURK FINANCE获取最新的金融和商业新闻。

通过销毁这些代币,Nexera旨在稳定其生态系统。该行动确保被盗和冻结的代币不会进入市场或进行交易,从而最大限度地减少其对市场的影响。

袭击期间发生了什么?

8月7日,Nexera遭遇安全漏洞,导致150万美元的加密资产被盗,其中包括NXRA代币。这次袭击是影响多个项目和协议的协同攻击的一部分。

黑客窃取了约4700万个NXRA代币,价值176万美元,其中一些用于以太坊(ETH),另一些则转移到BNB链。Nexera报告估计总损失为150万美元。该协议澄清说,没有必要发行新的NXRA令牌,因为现有的令牌地址保持不变。

用户被敦促避免交易NXRA代币。在攻击者与与黑客链接的地址进行交互后,KuCoin和MEXC等交易所暂停了服务。其他交易所也被通知采取类似的预防措施。

具体措施和建议

事件的关键措施和建议包括:

    立即冻结受损的代币,以防止进一步的市场影响。进行彻底的技术调查,以确保智能合约的完整性。与主要交易所协调,及时暂停相关服务。建议用户在调查期间不要进行交易。

这一安全漏洞发生在印度加密货币交易所WazirX发生类似事件几周后,该交易所发生了超过2.3亿美元的失窃事件,这是2024年第二大加密货币攻击事件。

您可以在Telegram、Twitter(X)和Coinmarketcap上关注我们的新闻。免责声明:本文所含信息不构成投资建议。投资者应该意识到加密货币具有高波动性,因此存在风险,应该进行自己的研究。

Letture associate

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

On August 10, 2026, BPL (300246.SZ) resumed trading after a nearly week-long suspension and immediately fell by a 20% limit-down. This plunge was triggered by the termination of a planned controlling stake transfer, dashing earlier market speculation. In January 2026, Zhejiang Quwei Zhihe Partnership entered as a significant shareholder, sparking hopes. Investors speculated that its backer, Weigu Information—a specialized "little giant" company in high-reliability solid-state storage chips—might be seeking a backdoor listing through BPL. This "cross-industry restructuring" expectation fueled a strong rally, with BPL's stock price more than doubling in 2026 prior to the halt. However, the deal was called off on August 7, directly causing the sharp sell-off. Underlying BPL's vulnerability is its fundamentally weak business. The company, a medical device firm, is mired in losses, having reported three consecutive years of net losses totaling over 200 million yuan. Its core hemodialysis business is squeezed by government procurement price cuts, while growth in its patient monitor segment has stalled. Furthermore, BPL faces imminent debt pressure with convertible bonds worth approximately 218 million yuan due in September 2026, and its current stock price is far below the conversion price. The failed control transfer may represent a delayed release of negative news, but BPL's core challenges remain: reversing operational losses and addressing its urgent liquidity crisis.

marsbit2 h fa

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

marsbit2 h fa

Trading

Spot
活动图片